360 related articles for article (PubMed ID: 34502491)
1. Autotaxin-LPA-LPP3 Axis in Energy Metabolism and Metabolic Disease.
Jose A; Kienesberger PC
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502491
[TBL] [Abstract][Full Text] [Related]
2. Role of the autotaxin-lysophosphatidate axis in the development of resistance to cancer therapy.
Tang X; Benesch MGK; Brindley DN
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158716. PubMed ID: 32305571
[TBL] [Abstract][Full Text] [Related]
3. Roles for lysophosphatidic acid signaling in vascular development and disease.
Smyth SS; Kraemer M; Yang L; Van Hoose P; Morris AJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Aug; 1865(8):158734. PubMed ID: 32376340
[TBL] [Abstract][Full Text] [Related]
4. Autotaxin inhibition reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction.
Tripathi H; Al-Darraji A; Abo-Aly M; Peng H; Shokri E; Chelvarajan L; R Donahue R; Levitan BM; Gao E; Hernandez G; Morris AJ; Smyth SS; Abdel-Latif A
J Mol Cell Cardiol; 2020 Dec; 149():95-114. PubMed ID: 33017574
[TBL] [Abstract][Full Text] [Related]
5. Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism.
D'Souza K; Nzirorera C; Cowie AM; Varghese GP; Trivedi P; Eichmann TO; Biswas D; Touaibia M; Morris AJ; Aidinis V; Kane DA; Pulinilkunnil T; Kienesberger PC
J Lipid Res; 2018 Oct; 59(10):1805-1817. PubMed ID: 30072447
[TBL] [Abstract][Full Text] [Related]
6. The Autotaxin-Lysophosphatidic Acid Axis Promotes Lung Carcinogenesis.
Magkrioti C; Oikonomou N; Kaffe E; Mouratis MA; Xylourgidis N; Barbayianni I; Megadoukas P; Harokopos V; Valavanis C; Chun J; Kosma A; Stathopoulos GT; Bouros E; Bouros D; Syrigos K; Aidinis V
Cancer Res; 2018 Jul; 78(13):3634-3644. PubMed ID: 29724718
[TBL] [Abstract][Full Text] [Related]
7. Autotaxin/Lysophosphatidic Acid Axis: From Bone Biology to Bone Disorders.
Alioli C; Demesmay L; Peyruchaud O; Machuca-Gayet I
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408784
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of the Lysophosphatidylcholine/Autotaxin/Lysophosphatidic Acid Axis in Acute-on-Chronic Liver Failure Is Associated With Mortality and Systemic Inflammation by Lysophosphatidic Acid-Dependent Monocyte Activation.
Trovato FM; Zia R; Napoli S; Wolfer K; Huang X; Morgan PE; Husbyn H; Elgosbi M; Lucangeli M; Miquel R; Wilson I; Heaton ND; Heneghan MA; Auzinger G; Antoniades CG; Wendon JA; Patel VC; Coen M; Triantafyllou E; McPhail MJ
Hepatology; 2021 Aug; 74(2):907-925. PubMed ID: 33908067
[TBL] [Abstract][Full Text] [Related]
9. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis.
Yang F; Chen GX
World J Gastroenterol; 2018 Sep; 24(36):4132-4151. PubMed ID: 30271079
[TBL] [Abstract][Full Text] [Related]
10. Mice with targeted inactivation of ppap2b in endothelial and hematopoietic cells display enhanced vascular inflammation and permeability.
Panchatcharam M; Salous AK; Brandon J; Miriyala S; Wheeler J; Patil P; Sunkara M; Morris AJ; Escalante-Alcalde D; Smyth SS
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):837-45. PubMed ID: 24504738
[TBL] [Abstract][Full Text] [Related]
11. Signalling by lysophosphatidate and its health implications.
Hemmings DG; Brindley DN
Essays Biochem; 2020 Sep; 64(3):547-563. PubMed ID: 32451553
[TBL] [Abstract][Full Text] [Related]
12. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic Acid Signaling in Obesity and Insulin Resistance.
D'Souza K; Paramel GV; Kienesberger PC
Nutrients; 2018 Mar; 10(4):. PubMed ID: 29570618
[TBL] [Abstract][Full Text] [Related]
14. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer.
Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN
FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654
[TBL] [Abstract][Full Text] [Related]
15. Biological roles of lysophosphatidic acid signaling through its production by autotaxin.
Okudaira S; Yukiura H; Aoki J
Biochimie; 2010 Jun; 92(6):698-706. PubMed ID: 20417246
[TBL] [Abstract][Full Text] [Related]
16. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis.
Orosa B; García S; Conde C
Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977
[TBL] [Abstract][Full Text] [Related]
17. Regulation of lysophosphatidate signaling by autotaxin and lipid phosphate phosphatases with respect to tumor progression, angiogenesis, metastasis and chemo-resistance.
Samadi N; Bekele R; Capatos D; Venkatraman G; Sariahmetoglu M; Brindley DN
Biochimie; 2011 Jan; 93(1):61-70. PubMed ID: 20709140
[TBL] [Abstract][Full Text] [Related]
18. Involvement of autotaxin/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis.
Rancoule C; Dusaulcy R; Tréguer K; Grès S; Attané C; Saulnier-Blache JS
Biochimie; 2014 Jan; 96():140-3. PubMed ID: 23639740
[TBL] [Abstract][Full Text] [Related]
19. [Function and biological activities of the autotaxin-LPA axis].
Li ZW; Zhao YR; Zhao C; Fu R; Li ZY
Sheng Li Xue Bao; 2011 Dec; 63(6):601-10. PubMed ID: 22193457
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of autotaxin/lysophospholipase d inhibitors.
Federico L; Pamuklar Z; Smyth SS; Morris AJ
Curr Drug Targets; 2008 Aug; 9(8):698-708. PubMed ID: 18691016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]